Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis

被引:12
作者
Yoong, Deborah [1 ]
Naccarato, Mark [1 ]
Sharma, Malika [2 ]
Wilton, James [3 ]
Senn, Heather [4 ]
Tan, Darrell H. S. [5 ,6 ,7 ]
机构
[1] St Michaels Hosp, Dept Pharm, 30 Bond St,4CC-N Rm 4-177, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Univ Hlth Network, Wilson Ctr Res Educ, Toronto, ON, Canada
[3] Canadian AIDS Treatment Informat Exchange, Toronto, ON, Canada
[4] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada
[5] St Michaels Hosp, Div Infect Dis, 30 Bond St, Toronto, ON M5B 1W8, Canada
[6] Univ Toronto, Toronto, ON, Canada
[7] Hassle Free Clin, Toronto, ON, Canada
关键词
HIV; AIDS; prevention; pre-exposure prophylaxis; PrEP; pharmacists; Canadian; ANTIRETROVIRAL PROPHYLAXIS; INFECTION; KNOWLEDGE; PROVIDERS; PREP; PRESCRIPTION; PREVENTION; RESISTANCE; ADHERENCE; COST;
D O I
10.1177/0956462415589896
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but has the potential to cause harm if not used properly. Pharmacists are well-positioned to foster PrEP's efficacy but little is known whether they would endorse it as an HIV prevention tool. The objective of the study was to determine Canadian HIV pharmacists' support for PrEP and to identify current barriers to promoting PrEP. Canadian pharmacists with experience in HIV care were invited to complete an online survey about their experiences, opinions, and learning needs regarding PrEP from December 2012 to January 2013. Among the 59 surveys received, 48 met criteria for final analysis. Overall, 33 (69%) respondents would provide education positively supporting the use of PrEP and 26 (54%) believed Health Canada should approve PrEP for use in Canada. Familiarity with the concept of PrEP and practice characteristics examined did not appear to be significantly associated with support for PrEP in univariable analyses. The principal barriers to promoting PrEP included inadequate drug coverage and insufficient knowledge to educate others. Many Canadian HIV pharmacists would endorse PrEP for high-risk patients; however, wider dissemination of information and lower drug costs may be needed to make PrEP more widely promoted.
引用
收藏
页码:608 / 616
页数:9
相关论文
共 50 条
  • [31] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
    Stein, Michael
    Thurmond, Portia
    Bailey, Genie
    [J]. AIDS AND BEHAVIOR, 2014, 18 (09) : 1694 - 1700
  • [32] An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection
    McGowan, Ian
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 71 (06) : 624 - 630
  • [33] Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis
    Magnus, Manya
    Yellin, Hannah
    Langlands, Kayley
    Balachandran, Madhu
    Turner, Melissa
    Jordan, Jeanne
    Ramin, Daniel
    Kuo, Irene
    Siegel, Marc
    [J]. JOURNAL OF MEDICINE ACCESS, 2023, 7
  • [34] Pre-exposure prophylaxis, a new tool for prevention against HIV
    Pialoux, G.
    Chas, J.
    Bonnard, P.
    [J]. JOURNAL DES ANTI-INFECTIEUX, 2012, 14 (04) : 175 - 179
  • [35] Pre-Exposure Prophylaxis Training among Medical Schools in the United States
    Cooper, Robert L.
    Tabatabai, Mohammad
    Juarez, Paul D.
    Ramesh, Aramandla
    Morris, Matthew C.
    Brown, Katherine Y.
    Arcury, Thomas A.
    Shinn, Marybeth
    Mena, Leandro A.
    Juarez, Patricia-Matthews
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2021, 12
  • [36] Pre-exposure prophylaxis in Southern Africa: feasible or not?
    Venter, Willem Daniel Francois
    Cowan, Frances
    Black, Vivian
    Rebe, Kevin
    Bekker, Linda-Gail
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18 : 35 - 41
  • [37] Reported Side Effects and Adherence of Daily HIV Pre-Exposure Prophylaxis Users in Ontario, Canada: An Analysis of the Ontario Pre-Exposure Prophylaxis Cohort Study
    Rudd, Monica
    McGarrity, Matthew
    Lisk, Ryan
    MacPherson, Paul
    Knox, David
    Woodward, Kevin
    Reinhart, Jeff
    MacLeod, John
    Bogoch, Isaac I.
    Clatworthy, Deanna
    Biondi, Mia J.
    Sullivan, Sean
    Li, Alan
    Durrant, Garfield
    Schonbe, Andrew
    Ongoiba, Fanta
    Burchell, Ann N.
    Tan, Darrell H. S.
    [J]. AIDS PATIENT CARE AND STDS, 2024, 38 (09) : 382 - 392
  • [38] Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis via CiteSpace
    Chen, Xi
    Lai, Yu
    [J]. FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [39] A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis
    Burns, Charles M.
    Endres, Kyle
    Derrick, Caroline
    Cooper, Alexandra
    Fabel, Patricia
    Okeke, Nwora Lance
    Ahuja, Divya
    Corneli, Amy
    McKellar, Mehri S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (04): : 329 - 338
  • [40] HIV Prevention After Discontinuing Pre-Exposure Prophylaxis: Conclusions From a Case Study
    Jonas, Kai J.
    Yaemim, Natthakhet
    [J]. FRONTIERS IN PUBLIC HEALTH, 2018, 6